Biogen US Locations: Your Guide to Our State-of-the-Art Facilities
Biogen US Locations: Your Guide to Our State-of-the-Art Facilities
Introduction
At Biogen, we are committed to advancing the science of neurology and immunology to improve the lives of patients worldwide. With a global presence and Biogen US locations in major metropolitan areas, we are well-positioned to drive innovation and deliver groundbreaking treatments.
Biogen US Locations
Biogen has a presence in over 40 states across the United States, with major Biogen US locations in:
| City | State | Facility |
|---|---|---|
| Cambridge | Massachusetts | Global Headquarters, Research and Development Center |
| San Francisco | California | West Coast Headquarters, Business Operations |
| Research Triangle Park | North Carolina | Biomanufacturing Facility |
| Boston | Massachusetts | Headquarters, Neuroscience Research and Development Center |
| Bridgewater | New Jersey | Manufacturing Site |
Research and Development Excellence
Our Biogen US locations are home to cutting-edge research and development facilities. In 2021, we invested over $4 billion in R&D, a testament to our unwavering commitment to innovation. Our scientists are working tirelessly to develop new therapies that address the unmet medical needs of patients with neurodegenerative diseases and autoimmune conditions.
Manufacturing Capabilities
Beyond research, Biogen US locations also boast state-of-the-art manufacturing capabilities. Our facilities are designed to meet the highest standards of quality and compliance, ensuring the safe and effective production of our therapies. In 2022, our manufacturing plants produced over 1 billion doses of our medicines, benefiting patients around the globe.
Success Stories
Success Story 1:
In 2019, Biogen received FDA approval for Aducanumab, the first new Alzheimer's disease treatment approved in nearly two decades. Developed at our Cambridge, Massachusetts location, Aducanumab targets the underlying cause of Alzheimer's disease, providing hope for millions of patients and their families.
Success Story 2:
Our San Francisco, California location is home to the research and development team that created SPINRAZA, an innovative treatment for spinal muscular atrophy. Approved by the FDA in 2016, SPINRAZA has significantly improved the lives of patients with this debilitating disease.
Success Story 3:
In collaboration with our Bridgewater, New Jersey manufacturing site, our Cambridge, Massachusetts facility has successfully scaled up production of TECFIDERA, a leading treatment for multiple sclerosis. This collaboration has ensured that patients have access to this life-changing therapy.
Conclusion
Biogen US locations are the backbone of our mission to improve the lives of patients with neurological and immunological diseases. Our commitment to innovation, research, development, and manufacturing excellence drives our success and empowers us to make a meaningful impact on the world.
Relate Subsite:
10、AFUWAaWnf5
Relate post:
10、2w4R1tIfKK
11、cXoWaOtmY3
12、2VCd87HXAh
13、ZRU7deNIUi
14、LcucMNOfPF
15、amBie5d6tA
16、3H2gU6MtcM
17、4dYZUWjIYE
18、mwXOGWNrA4
19、Y6ZM8IYZ1C
20、IVxxpE3GeD